- Home
- MLYS vs MPB Comparison
MLYS vs MPB Comparison
Compare MLYS & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- MPB
- Stock Information
- Founded
- MLYS 2019
- MPB 1868
- Country
- MLYS United States
- MPB United States
- Employees
- MLYS N/A
- MPB N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- MPB Major Banks
- Sector
- MLYS Health Care
- MPB Finance
- Exchange
- MLYS Nasdaq
- MPB Nasdaq
- Market Cap
- MLYS 1.0B
- MPB 634.9M
- IPO Year
- MLYS 2023
- MPB N/A
- Fundamental
- Price
- MLYS $14.54
- MPB $30.22
- Analyst Decision
- MLYS Strong Buy
- MPB Buy
- Analyst Count
- MLYS 4
- MPB 2
- Target Price
- MLYS $27.00
- MPB $36.00
- AVG Volume (30 Days)
- MLYS 862.9K
- MPB 99.3K
- Earning Date
- MLYS 08-12-2025
- MPB 07-23-2025
- Dividend Yield
- MLYS N/A
- MPB 2.65%
- EPS Growth
- MLYS N/A
- MPB 23.94
- EPS
- MLYS N/A
- MPB 2.88
- Revenue
- MLYS N/A
- MPB $181,865,000.00
- Revenue This Year
- MLYS N/A
- MPB $24.31
- Revenue Next Year
- MLYS N/A
- MPB $13.74
- P/E Ratio
- MLYS N/A
- MPB $10.50
- Revenue Growth
- MLYS N/A
- MPB 9.21
- 52 Week Low
- MLYS $8.24
- MPB $21.11
- 52 Week High
- MLYS $18.38
- MPB $33.87
- Technical
- Relative Strength Index (RSI)
- MLYS 47.97
- MPB 75.03
- Support Level
- MLYS $13.22
- MPB $28.02
- Resistance Level
- MLYS $14.54
- MPB $28.48
- Average True Range (ATR)
- MLYS 0.71
- MPB 0.60
- MACD
- MLYS 0.00
- MPB 0.33
- Stochastic Oscillator
- MLYS 68.37
- MPB 100.00
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.